Managing Dyskinesia Through Continuous Infusion Therapy

Continuous infusion therapies are becoming an important treatment option for people with Parkinson’s who experience motor fluctuations or troublesome dyskinesia. Unlike oral medications, which can lose consistency over time, infusion therapies provide steady delivery of medication to help reduce “off” periods and smooth out symptoms. What This Means for Daily Life Research and real-world experience show that infusion therapies can improve quality of life by offering more reliable control of both movement and non-movement symptoms. Subcutaneous and intestinal systems are already helping many people, and newer devices are being designed to be easier and more comfortable to use. Looking to the Future As care becomes more personalized, infusion therapies may be offered earlier and to more people who could benefit. Ongoing research is exploring new medications for continuous delivery and tools like biomarkers that could guide when and how these therapies are introduced. Why It Matters For people living with Parkinson’s, infusion therapies represent progress toward more stable, long-term management. While not a cure, they are an important step forward in supporting independence, reducing complications, and improving daily life.